Antifibrinolytics Explained: Agents, Mechanisms, Uses, and Safety Profile

Antifibrinolytics: List of Agents, Mechanism of Action, Indications, Adverse Effects & Contraindications

Introduction to Antifibrinolytics

  • Definition: Antifibrinolytics are drugs that inhibit fibrinolysis (the breakdown of fibrin), stabilizing clots.
  • Purpose: Reduce bleeding in surgery, trauma, or disorders with hyperfibrinolysis.

List of Antifibrinolytic Agents

  • Synthetic Lysine Analogs:
    • Epsilon Aminocaproic Acid (EACA)
    • Tranexamic Acid (TXA)
  • Protease Inhibitor:
    • Aprotinin (Bovine origin)

Mechanism of Action

  • EACA & TXA:
    • Inhibit activation of plasminogen to plasmin.
    • Block lysine binding sites on plasminogen/plasmin.
  • Aprotinin:
    • Serine protease inhibitor.
    • Inhibits plasmin, kallikrein, and trypsin.

Indications

  • EACA:
    • Cardiac surgery
    • Hemophilia
    • Urinary bleeding
  • Tranexamic Acid:
    • Trauma-associated bleeding
    • Heavy menstrual bleeding
    • Dental procedures in hemophilia
    • Surgery (e.g., orthopedic, cardiac)
  • Aprotinin (historical use):
    • Cardiac surgery to reduce blood loss (limited due to safety concerns)

Adverse Effects

  • EACA:
    • Hypotension (if given IV too rapidly)
    • Muscle necrosis
    • Thrombosis
  • Tranexamic Acid:
    • Nausea, vomiting
    • Visual disturbances (rare)
    • Risk of thrombosis (controversial)
  • Aprotinin:
    • Anaphylaxis (especially with repeat use)
    • Renal dysfunction
    • Increased mortality (led to withdrawal in some regions)

Contraindications

  • EACA:
    • Active intravascular clotting
    • Disseminated intravascular coagulation (DIC) without heparin
  • Tranexamic Acid:
    • History of thrombosis
    • Subarachnoid hemorrhage (risk of cerebral edema)
  • Aprotinin:
    • Previous hypersensitivity
    • Use cautiously in patients with renal impairment

Important Point

  • TXA is widely used in trauma and orthopedic surgeries with good safety profile.
  • EACA is cheaper but less potent than TXA.
  • Aprotinin is restricted due to safety concerns but may still be used in select cases.

                                                                  END OF THE CHAPTER

You may also like read more: 

SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

  • Image
  • Image
  • Image
  • Image
  • Image
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment